Study of Novel Triple Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori in Children
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Number of patients with cured helicobacter infection
研究概览
简要总结
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
详细描述
Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Positive helicobacter infection.
排除标准
- •Previous treatment for H. Pylori.
研究组 & 干预措施
Nitazoxanide group
Clarithromycin, Nitazoxanide and Proton pump inhibitor
干预措施: Nitazoxanide (Drug)
Nitazoxanide group
Clarithromycin, Nitazoxanide and Proton pump inhibitor
干预措施: Clarithromycin (Drug)
Nitazoxanide group
Clarithromycin, Nitazoxanide and Proton pump inhibitor
干预措施: Proton pump inhibitor (Drug)
Traditional group
Clarithromycin, Metronidazole and Proton pump inhibitor
干预措施: Clarithromycin (Drug)
Traditional group
Clarithromycin, Metronidazole and Proton pump inhibitor
干预措施: Metronidazole (Drug)
Traditional group
Clarithromycin, Metronidazole and Proton pump inhibitor
干预措施: Proton pump inhibitor (Drug)
结局指标
主要结局
Number of patients with cured helicobacter infection
时间窗: 6 months
Total number of patients with eradicated helicobacter infection
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University